Microscale Axon Repair As A Novel Paradigm For Nerve Injuries

微型轴突修复作为神经损伤的新范例

基本信息

项目摘要

DESCRIPTION (provided by applicant): Injuries to the central nervous system result in permanent disability and represent a major unmet challenge in medicine today. In addition to the devastating impact on patient quality of life, these injuries impose a large economic burden on society. Although substantial research efforts are underway to promote the regeneration of injured nerve cell axons, the re-establishment of functional neural circuits remains a distant goal. In contrast, little attention has been paid to the possibility that axons may be surgically repaired at the cellular level in the acute setting to reconstitute function. The barrier to this approach is of course the fact that the precise manipulation of axons as small as one micron in diameter is beyond our current surgical technology. However, it is precisely at this small length scale that micro and nanotechnology excel. In recent work, we developed prototype micro and nanodevices that utilize short-range electrokinetic phenomenon to demonstrate early technical proof of principle for this approach. In this application for EUREKA funding, we propose to critically examine axon micro-repair from a biological perspective in order to determine the true potential of this novel methodology for nerve injury treatment. We will specifically investigate to what degree axonal function is reconstituted after the fusion repair or splicing together of two axon segments. In particular we will address whether the propagation of action potential activity and axonal transport can be demonstrated to occur in axon segments that have been reconnected with one another. Microdevice-assisted reconstruction of axons represents a paradigm shift compared to conventional approaches of stimulating axon re-growth and regeneration after injury. The results from this study may provide the biological underpinnings to a potentially new method of nerve repair and help meet an urgent clinical need. PUBLIC HEALTH RELEVANCE: The experimental studies proposed in this EUREKA application explore the biological underpinnings for a potentially new method of nerve repair. Since medicine today offers no specific therapy that can reconstitute function after injuries to neural pathways, this project has direct relevance to an area of clinical need.
描述(由申请人提供):中枢神经系统损伤会导致永久性残疾,是当今医学领域尚未解决的重大挑战。除了对患者生活质量造成破坏性影响外,这些伤害还给社会带来巨大的经济负担。尽管正在进行大量研究工作来促进受损神经细胞轴突的再生,但功能神经回路的重建仍然是一个遥远的目标。相比之下,很少有人关注在急性环境下通过手术在细胞水平上修复轴突以重建功能的可能性。当然,这种方法的障碍是,精确操纵直径小至一微米的轴突超出了我们当前的外科技术。然而,微米和纳米技术正是在如此小的长度尺度上表现出色。在最近的工作中,我们开发了原型微型和纳米器件,利用短程电动现象来证明这种方法原理的早期技术证明。在本次 EUREKA 资助申请中,我们建议从生物学角度严格检查轴突微修复,以确定这种新颖的神经损伤治疗方法的真正潜力。我们将具体研究两个轴突片段融合修复或拼接在一起后轴突功能重建的程度。特别是,我们将讨论是否可以证明动作电位活动和轴突运输的传播发生在彼此重新连接的轴突片段中。与损伤后刺激轴突再生长和再生的传统方法相比,微设备辅助轴突重建代表了范式转变。这项研究的结果可能为神经修复的潜在新方法提供生物学基础,并有助于满足紧迫的临床需求。公共健康相关性:本 EUREKA 申请中提出的实验研究探索了一种潜在的神经修复新方法的生物学基础。由于当今的医学没有提供可以在神经通路损伤后重建功能的特定疗法,因此该项目与临床需求领域直接相关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID W SRETAVAN其他文献

DAVID W SRETAVAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID W SRETAVAN', 18)}}的其他基金

Microscale Axon Repair As A Novel Paradigm For Nerve Injuries
微型轴突修复作为神经损伤的新范例
  • 批准号:
    7503958
  • 财政年份:
    2008
  • 资助金额:
    $ 2.59万
  • 项目类别:
Microscale Axon Repair As A Novel Paradigm For Nerve Injuries
微型轴突修复作为神经损伤的新范例
  • 批准号:
    8094388
  • 财政年份:
    2008
  • 资助金额:
    $ 2.59万
  • 项目类别:
Microscale Axon Repair As A Novel Paradigm For Nerve Injuries
微型轴突修复作为神经损伤的新范例
  • 批准号:
    7647954
  • 财政年份:
    2008
  • 资助金额:
    $ 2.59万
  • 项目类别:
Axon Guidance Molecules and Optic Nerve Disease
轴突引导分子与视神经疾病
  • 批准号:
    7497727
  • 财政年份:
    2005
  • 资助金额:
    $ 2.59万
  • 项目类别:
Axon Guidance Molecules and Optic Nerve Disease
轴突引导分子与视神经疾病
  • 批准号:
    6955762
  • 财政年份:
    2005
  • 资助金额:
    $ 2.59万
  • 项目类别:
Axon Guidance Molecules and Optic Nerve Disease
轴突引导分子与视神经疾病
  • 批准号:
    7100154
  • 财政年份:
    2005
  • 资助金额:
    $ 2.59万
  • 项目类别:
Axon Guidance Molecules and Optic Nerve Disease
轴突引导分子与视神经疾病
  • 批准号:
    7271197
  • 财政年份:
    2005
  • 资助金额:
    $ 2.59万
  • 项目类别:
CORE--MOLECULAR BIOLOGY SUPPORT MODULE
核心--分子生物学支持模块
  • 批准号:
    6713451
  • 财政年份:
    2003
  • 资助金额:
    $ 2.59万
  • 项目类别:
Imaging Analysis and Graphics Core
图像分析和图形核心
  • 批准号:
    10665567
  • 财政年份:
    1997
  • 资助金额:
    $ 2.59万
  • 项目类别:
MOLECULAR DEVELOPMENT OF RETINAL GANGLION CELL AXON PATHWAYS
视网膜神经节细胞轴突通路的分子发育
  • 批准号:
    6247842
  • 财政年份:
    1997
  • 资助金额:
    $ 2.59万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.59万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 2.59万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.59万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.59万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.59万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.59万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.59万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 2.59万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 2.59万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 2.59万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了